740 Dr Penfield: McGill University and Génome Québec Innovation Centre

The McGill University and Génome Québec Innovation Centre is a world class research facility for genomics and proteomics. Founded by Dr Tom Hudson and initially focused on complex genetic disorders such as cardiac disease and asthma, the centre has become a networking site for a wide range of research initiatives including haplotyping of the human genome (HapMap) and defining the regulatory mechanisms of gene expression. The Centre, located at 740 Dr Penfield, acts as a vast resource of knowledge and technology to the academic, industrial and commercial sectors.

The McGill Univeristy and Génome Québec Innovation Centre is proud to act as a development facility for the future leaders in genomic and proteomic research and development. The facility supports the training of post-doctoral fellows and graduate students in new biotechnologies and acts as a beta-site for developing new research products.

The Centre also operates four service platforms that provide a wide range of high quality genomic and proteomic services to academic and commercial clients across Quebec and North America. These services include genotyping, sequencing, and microarray and proteomic analysis.

The McGill University and Génome Québec Innovation Centre is an integral part of today's genomic and proteomic fields. The facility, previously known as the Montreal Genome Centre, would not exist without the continued funding from the Canada Foundation for Innovation, the Quebec government, Génome Québec, BioChem Pharma, Applied Biosystems and others.

For more information on the McGill University and Génome Québec Innovation Centre, visit the web site.